Celebrating 25 Years of Innovation

As the pioneers in vacuum-assisted breast biopsy, Mammotome is proud to celebrate 25 years of innovation. It all began with the original Mammotome Vacuum Assisted Breast Biopsy System, which transformed breast cancer intervention from open surgical biopsy to minimally invasive procedures. From these early days, Mammotome focused on providing best-in-class technology to help clinicians accurately diagnose breast cancer.

HONORING OUR PAST, FOCUSING ON THE FUTURE

Today, Mammotome remains committed to advancing breast care by discovering new opportunities to deliver better solutions. We strive to be the trusted leader in breast cancer diagnostics and surgical solutions, accomplished through strong product performance, trusted partnerships and an unwavering focus on patient outcomes.

A GLOBAL COMPANY WITH A LOCAL PRESENCE

A proud operating company of Danaher Corporation since 2014, Mammotome is headquartered in Cincinnati, Ohio. The Mammotome brand is sold in over 45 different countries throughout the world. To date, more than 10 million women worldwide have had a procedure using a minimally invasive Mammotome breast biopsy system.

OUR CORE VALUES

The Mammotome team comes from a diverse array of backgrounds and experiences, but together, we all share a strong commitment to our core values.

It Begins With Us
Employees are our most valuable asset. We are committed to their growth and development.
We Work to Improve Every Day
We encourage a culture of continuous improvement.
We Deliver Results
Our brands empower our growth. We are the partner of choice.
Our Priority is the Patient’s Experience
We focus on providing high quality products.
Innovate for Today and Tomorrow
We find ways to get better results through current and new technologies.

Mammotome - Model Neoprobe - Gamma Detection System Brochure